🔎 Trials Near Me

Akèy › Limfom selil mantèl › Minnesota › Rochester

Etid klinik pou Limfom selil mantèl nan Rochester, MN

9 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Ap rekriteFaz 1/2
  • Research Site, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Ap rekriteFaz 1/2
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • Mayo Clinic, Clinical Trials Referral Office, Rochester
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Ap rekriteFaz 2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Nov 18, 2024 · NCT05910801

Etid Limfom selil mantèl nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.